- Flow Wellness, accessed April 22, 2025, 8 Zepbound Side Effects: Common and Severe and How to Manage Them - NP2GO, accessed April 22, 2025, GLP-1 physiology informs the pharmacotherapy of obesity - PubMed, accessed April 22, 2025, Creating a GLP-1 Meal Plan | Visit MRC Auburn - Metabolic Research Center, accessed April 22, 2025, Food Noise and Semaglutide: Can GLP-1 Medications Quiet the Chatter
This article examines the clinical considerations, potential interactions, side effects, and monitoring requirements when Wegovy and lisdexamfetamine are used together, in line with UK guidance from NICE, MHRA, and the BNF
In contrast to the potential dangerous effects in the acceleration of atherosclerosis, mixed results have been reported with L-carnitine supplementation in the immediate setting following an acute myocardial infarction (AMI)
For weight management, NICE recommends semaglutide 2.4mg (Wegovy) for adults with a BMI 35 kg/m (or 30 kg/m with weight-related comorbidities) within specialist weight management services alongside lifestyle interventions (TA875)
28 , 503514.e4 (2018)
For patients with pre-existing respiratory or cardiac conditions, any change in baseline breathing patterns should be reported to their GP, as this may indicate deterioration of the underlying condition rather than a medication effect